Monitor for Biogy's answer and subsequent discovery milestones. A claim construction (Markman) hearing could define the scope of the patent claims and materially shift the risk profile. If Okta's products are found to infringe, exposure extends to all customers using standard TOTP authentication, creating substantial indemnification liability. Track any forthcoming customer indemnification demands and watch for parallel cases involving Microsoft in the same court.
Price Chart
Executive Summary
The District Court for the Northern District of California denied Biogy's motion to dismiss Okta's declaratory judgment action seeking a declaration of non-infringement of U.S. Patent No. 7,669,236. The ruling establishes that Okta has standing to proceed, meaning the patent dispute will continue through litigation on the merits rather than being terminated at the threshold jurisdictional stage. For Okta, this extends legal uncertainty over a core security technology (TOTP authentication) that underpins its identity platform, which carries moderate negative implications given the patent covers a widely-used standard.
Court Ruling Details
Key Facts
- Court denied Biogy's motion to dismiss for lack of subject matter jurisdiction.
- Okta's declaratory judgment action to establish non-infringement of the '236 Patent will proceed.
- Patent covers RFC 6238 Time-Based One-Time Passcode (TOTP) standard — a core component of Okta's multi-factor authentication products.
- Biogy has sent infringement letters to Okta customers (including Albertsons and Parker Hannifin).
- Okta has existing indemnification obligations to customers receiving such letters, creating concrete exposure.
- The court distinguished this case from Mitek II, finding the infringement allegations relate to Okta's standard products, not customized implementations.
Financial Impact
No damages awarded. Financial exposure stems from potential indemnification costs for customers and future patent litigation risk. The '236 Patent covers a foundational TOTP standard used broadly in Okta's core identity platform.
Risk Factors
- Adverse claim construction or summary judgment ruling finding infringement could open significant indemnification obligations to Okta's customer base.
- Parallel litigation (Microsoft v. Biogy in same court) may produce precedent that constrains or expands the risk.
- Broad application of the patent to the TOTP standard could require Okta to modify product architecture, incurring engineering and compliance costs.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 1 court opinion from CourtListener.
| Document | Accession Number |
|---|---|
| COURT-RULING Data (Synthetic) | court-1lakvsmm-OKTA |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Jun 23, 2026 14w ago | 8-K | $118.58 $190.02 | ▲ +60.25% | ▲ +57.41% | $213.74 (+80.25%) |
May 28, 2026 18w ago | 8-K | $123.27 $130.97 | ▲ +6.25% | ▲ +5.06% | $213.74 (+73.39%) |
May 7, 2026 21w ago | DEFA14A | $83.85 $141.57 | ▲ +68.83% | ▲ +66.11% | $213.74 (+154.90%) |
Mar 23, 2026 27w ago | 8-K | $80.69 $116.27 | ▲ +44.09% | ▲ +29.60% | $213.74 (+164.88%) |
Mar 19, 2026 28w ago | Insider Cluster | $80.71 $117.58 | ▲ +45.68% | ▲ +31.34% | $213.74 (+164.81%) |
Mar 19, 2026 28w ago | Insider Cluster | $80.71 $117.58 | ▼ −45.68% | ▼ −31.34% | $213.74 (−164.81%) |
Mar 11, 2026 29w ago | 8-K | $78.63 $118.72 | ▲ +50.98% | ▲ +40.28% | $213.74 (+171.82%) |
Mar 4, 2026 30w ago | 8-K | $79.30 $139.79 | ▲ +76.27% | ▲ +64.97% | $213.74 (+169.52%) |
Feb 23, 2026 31w ago | Court Ruling | $69.51 $85.70 | ▼ −23.29% | ▼ −15.77% | $213.74 (−207.50%) |
US Market Status
Subscribe to SecBot
Get Real-Time Court Ruling Intelligence
Market-moving court rulings analyzed within minutes. Patent verdicts, antitrust decisions, class certifications, and more — parsed and scored by AI.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access